The effect on serum myeloperoxidase activity and oxidative status of eradication treatment in patients Helicobacter pylori infected

Clinical Biochemistry

Volumn 44, Issue 8-9, 2011, Pages 647-649

  Nazligul, Yaşar ^a   Aslan, Mehmet ^b   Horoz, Mehmet ^c   Celik, Yilmaz ^d   Dulger, Ahmet Cumhur ^d   Celik, Hakim ^c   Erel, Ozcan ^c  

^a Kecioren Hospital Ankara   (Turkey)

^b Ozel Ercis Capa Medicine Center   (Turkey)

^c HARRAN UNIVERSITY   (Turkey)

^d YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Helicobacter pylori; Myeloperoxidase activity; Oxidative stress index; Total antioxidant capacity; Total oxidant status

Indexed keywords

BIOLOGICAL MARKER; MYELOPEROXIDASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; STOMACH BIOPSY; TISSUE SECTION;

ADULT; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PEROXIDASE; YOUNG ADULT;

EID: 79955867090     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.03.001     Document Type: Article

References (35)

1. Blaser M.J. Helicobacter pylori: its role in disease. Clin Infect Dis 1992, 15:386-391.
2. Leontiadis G.I., Sharma V.K., Howden C.W. Non-gastrointestinal tract associations of Helicobacter pylori infection. Arch Intern Med 1999, 159:925-940.
3. Ernst P. Review article: the role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol Ther 1999, 13:13-18.
4. Andersen L.P. The antibody response to Helicobacter pylori infection, and the value of serologic tests to detect H pylori and for post-treatment monitoring. Biology and clinical practice 1993, 285-305. CRC Press, London. C.S. Goodwin, B.W. Worsley (Eds.).
5. Marshall B.J., Warren J.R. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983, 1:1273-1275.
6. Nøorgaard A., Andersen L.P., Nielsen H. Neutrophil degranulation by Helicobacter pylori proteins. Gut 1995, 36:354-357.
7. Kim J.S., Jung H.C., Kim J.M., Song I.S., Kim C.Y. Helicobacter pylori watersoluble surface proteins activate human neutrophils and up-regulate expression of CXC chemokines. Dig Dis Sci 2000, 45:83-92.
8. Winterbourn C.C., Vissers M.C., Kettle A.J. Myeloperoxidase. Curr Opin Hematol 2000, 7(1):53-58.
9. Podrez E.A., Abu-Soud H.M., Hazen S.L. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 2000, 28:1717-1725.
10. Hazell L.J., Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J 1993, 290:165-172.
11. Daugherty A., Rateri D.L., Dunn J.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994, 94:437-444.
12. Nagra R.M., Becher B., Tourtellotte W.W., Antel J.P., Gold D., Paladino T., et al. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmune 1997, 78:97-107.
13. Sasayama Y., Kawano S., Tsuji S., Fusamoto H., Kamada T., Fukui H., et al. Relationship between interleukin-8 levels and myeloperoxidase activity in human gastric mucosa. J Gastroenterol Hepatol 1997, 12(2):104-108.
14. Nishizawa T., Suzuki H., Nakagawa I., Minegishi Y., Masaoka T., Iwasaki E., et al. Early Helicobacter pylori eradication restores sonic hedgehog expression in the gastric mucosa of Mongolian gerbils. Digestion 2009, 79(2):99-108.
15. Noshiro M., Kusugami K., Sakai T., Imada A., Ando T., Ina K., et al. Gastric metaplasia in the duodenal bulb shows increased mucosal interleukin-8 activity in Helicobacter pylori-positive duodenal ulcer patients. Scand J Gastroenterol 2000, 35(5):482-489.
16. Suzuki M., Mori M., Miyayama A., Iwai N., Tsunematsu N., Oonuki M., et al. Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication. J Clin Gastroenterol 1997, 25:222-228.
17. Keto Y., Takahashi S., Okabe S. Healing of Helicobacter pylori-induced gastric ulcers in Mongolian gerbils: combined treatment with omeprazole and clarithromycin. Dig Dis Sci 1999, 44:257-265.
18. Akcam M., Elmas O., Yilmaz A., Caglar S., Artan R., Gelen T., et al. Myeloperoxidase, xanthine oxidase and superoxide dismutase in the gastric mucosa of Helicobacter pylori positive and negative pediatric patients. Mol Cell Biochem 2006, 290:125-130.
19. Marostica M., Arçari D.P., Bartchewsky W., Trevisan M., Ribeiro M.L., Pedrazzoli J., et al. Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice. Scand J Gastroenterol 2007, 42:1404-1412.
20. Fukuda M., Shirasaka D., Aoyama N., Miki I., Kachi M., Morita Y., et al. No significant difference in neutrophil activation found among three H2RAs. Dig Liver Dis 2007, 39(2):130-135.
21. Dixon M.F., Genta R.M., Yardley J.H., Correa P. Classification and grading of gastritis. The updated System of Sydney. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996, 20:1161-1181.
22. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004, 37:112-119.
23. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005, 38:1103-1111.
24. Bolukbas C., Bolukbas F.F., Horoz M., Aslan M., Celik H., Erel O. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis 2005, 5:95.
25. Klebanoff S.J., Clark R.A. The neutrophil: function and clinical disorders 1978, 1:810. Elsevier/North Holland Biomedical Press, Amsterdam, The Netherlands.
26. Davies G.R., Simmonds N.J., Stevens T.R., Grandison A., Blake D.R., Rampton D.S. Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 1992, 33:1467-1472.
27. Khanzode S.S., Khanzode S.D., Dakhale G.N. Serum and plasma concentration of oxidant and antioxidants in patients of Helicobacter pylori gastritis and its correlation with gastric cancer. Cancer Lett 2003, 195:27-31.
28. Miyazawa T. Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radic Biol Med 1989, 7:209-217.
29. Misiewicz J.J. Current insights in the pathogenesis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995, 7:701-703.
30. Asahi M., Azuma T., Ito S., Ito Y., Suto H., Nagai Y., et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 2000, 191:593-602.
31. Aslan M., Nazligul Y., Horoz M., Bolukbas C., Bolukbas F.F., Aksoy N., et al. Serum prolidase activity and oxidative status in Helicobacter pylori infection. Clin Biochem 2007, 40:37-40.
32. Sugiyama S., Okada Y., Sukhova G.K., Virmani R., Heinecke J.W., Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001, 158(3):879-891.
33. Brennan M.L., Hazen S.L. Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment. Curr Opin Lipidol 2003, 14:353-359.
34. Kutter D., Devaquet P., Vanderstocken G., Paulus J.M., Marchal V., Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit?. Acta Haematol 2000, 104(1):10-15.
35. Zhang R., Brennan M.L., Fu X., Aviles R.J., Pearce G.L., Penn M.S., et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001, 286(17):2136-2142.